Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Feld

Showing results (251-260 of 451) with videos related to

Pageof 46
Sort By:
Canadian Journal of Gastroenterology & Hepatology|July 23, 2016
Highlights of the Fourth Canadian Symposium on Hepatitis C: Moving towards a National Action PlanSelena M Sagan, Benoit Dupont, Jason Grebely, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|January 19, 2020
A Systematic Review and Meta-Analysis of Health Utilities in Patients With Chronic Hepatitis CYasmin A Saeed, Arcturus Phoon, Joanna M Bielecki, et al.
Plos One|August 23, 2018
Identifying cirrhosis, decompensated cirrhosis and hepatocellular carcinoma in health administrative data: A validation studyLauren Lapointe-Shaw, Firass Georgie, David Carlone, et al.
BMC Public Health|September 5, 2020
Hepatitis C virus infection characteristics and treatment outcomes in Canadian immigrantsCurtis L Cooper, Daniel Read, Marie-Louise Vachon, et al.
Diabetes Care|March 31, 2018
Relationship Between Metabolic Syndrome, Alanine Aminotransferase Levels, and Liver Disease Severity in a Multiethnic North American Cohort With Chronic Hepatitis BMandana Khalili, Margaret C Shuhart, Manuel Lombardero, et al.
Journal of Hepatology|June 25, 2017
Safety of the 2D/3D direct-acting antiviral regimen in HCV-induced Child-Pugh A cirrhosis - A pooled analysisFred Poordad, David R Nelson, Jordan J Feld, et al.
JAMA Network Open|May 7, 2020
Assessment of Treatment Strategies to Achieve Hepatitis C Elimination in Canada Using a Validated ModelMawuena Binka, Naveed Z Janjua, Jason Grebely, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 25, 2016
Applicability of Hepatitis C Virus RNA Viral Load Thresholds for 8-Week Treatments in Patients With Chronic Hepatitis C Virus Genotype 1 InfectionJohannes Vermehren, Benjamin Maasoumy, Raoel Maan, et al.
Canadian Liver Journal|August 22, 2022
The 8<sup>th</sup> Canadian Symposium on Hepatitis C virus: "Improving diagnosis and linkage to care"Sophie E Cousineau, Aysegul Erman, Lewis Liu, et al.
Canadian Liver Journal|August 22, 2022
Direct-acting antiviral treatment uptake and sustained virological response outcomes are not affected by alcohol use: A CANUHC analysisMatt Driedger, Marie-Louise Vachon, Alexander Wong, et al.
Pageof 46

Showing results (251-260 of 451) with videos related to

Sort By:
Pageof 46
Canadian Journal of Gastroenterology & Hepatology|July 23, 2016
Highlights of the Fourth Canadian Symposium on Hepatitis C: Moving towards a National Action PlanSelena M Sagan, Benoit Dupont, Jason Grebely, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|January 19, 2020
A Systematic Review and Meta-Analysis of Health Utilities in Patients With Chronic Hepatitis CYasmin A Saeed, Arcturus Phoon, Joanna M Bielecki, et al.
Plos One|August 23, 2018
Identifying cirrhosis, decompensated cirrhosis and hepatocellular carcinoma in health administrative data: A validation studyLauren Lapointe-Shaw, Firass Georgie, David Carlone, et al.
BMC Public Health|September 5, 2020
Hepatitis C virus infection characteristics and treatment outcomes in Canadian immigrantsCurtis L Cooper, Daniel Read, Marie-Louise Vachon, et al.
Diabetes Care|March 31, 2018
Relationship Between Metabolic Syndrome, Alanine Aminotransferase Levels, and Liver Disease Severity in a Multiethnic North American Cohort With Chronic Hepatitis BMandana Khalili, Margaret C Shuhart, Manuel Lombardero, et al.
Journal of Hepatology|June 25, 2017
Safety of the 2D/3D direct-acting antiviral regimen in HCV-induced Child-Pugh A cirrhosis - A pooled analysisFred Poordad, David R Nelson, Jordan J Feld, et al.
JAMA Network Open|May 7, 2020
Assessment of Treatment Strategies to Achieve Hepatitis C Elimination in Canada Using a Validated ModelMawuena Binka, Naveed Z Janjua, Jason Grebely, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 25, 2016
Applicability of Hepatitis C Virus RNA Viral Load Thresholds for 8-Week Treatments in Patients With Chronic Hepatitis C Virus Genotype 1 InfectionJohannes Vermehren, Benjamin Maasoumy, Raoel Maan, et al.
Canadian Liver Journal|August 22, 2022
The 8<sup>th</sup> Canadian Symposium on Hepatitis C virus: "Improving diagnosis and linkage to care"Sophie E Cousineau, Aysegul Erman, Lewis Liu, et al.
Canadian Liver Journal|August 22, 2022
Direct-acting antiviral treatment uptake and sustained virological response outcomes are not affected by alcohol use: A CANUHC analysisMatt Driedger, Marie-Louise Vachon, Alexander Wong, et al.
Pageof 46